ALNY
Alnylam Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ALNY fundamentals
Alnylam Pharmaceuticals (ALNY) released its earnings on Oct 30, 2025: revenue was 1.25B (YoY +149.54%), beat estimates; EPS was 2.9 (YoY +680.00%), beat estimates.
Revenue / YoY
1.25B
+149.54%
EPS / YoY
2.9
+680.00%
Report date
Oct 30, 2025
ALNY Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 2025 net product revenues up 103% YoY to $851 million, driven by 135% TTR franchise expansion.
- Guidance Increase: 2025 net product revenue raised to $2.95B-$3.05B (midpoint +10%), reflecting AMVUTTRA ATTR-CM launch strength.
- U.S. Launch Momentum: AMVUTTRA ATTR-CM Q3 net sales $543 million (+100% QoQ), with 90% U.S. patients within 10 miles of treatment.
- Pipeline Progress: ZENITH hypertension trial initiated; ALN-6400 Phase II in HHT; MAPT Phase I in Alzheimer's.
- Financial Discipline: Non-GAAP operating income $476 million (+128% YoY); cash balance $2.7 billion post-refinancing.
EPS
Revenue
Revenue & Expenses
ALNY has released its 2025 Q3 earnings report, with revenue of 1.25B, reflecting a YoY change of 149.35%, and net profit of 251.08M, showing a YoY change of 325.05%. The Sankey diagram below clearly presents ALNY's revenue sources and cost distribution.
Key Indicators
Alnylam Pharmaceuticals (ALNY) key financial stats and ratios, covering profitability, financial health, and leverage.
Alnylam Pharmaceuticals (ALNY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Alnylam Pharmaceuticals (ALNY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Alnylam Pharmaceuticals (ALNY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Alnylam Pharmaceuticals (ALNY) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Alnylam Pharmaceuticals (ALNY) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Alnylam Pharmaceuticals's revenue and profit?What is the market's earnings forecast for Alnylam Pharmaceuticals next quarter?Did Alnylam Pharmaceuticals beat or miss consensus estimates last quarter?What guidance did Alnylam Pharmaceuticals's management provide for the next earnings period?What is the revenue and EPS growth rate for Alnylam Pharmaceuticals year over year?What is Alnylam Pharmaceuticals's latest dividend and current dividend yield?What is Alnylam Pharmaceuticals's gross profit margin?What does Alnylam Pharmaceuticals do and what are its main business segments?
